A cap that can diagnose Alzheimer’s early

July 13, 2020

The team at BrainWaveBank are hoping that a neoprene cap with a series of electrodes on the inside can become a tool for helping diagnose neurological disorders such as Alzheimer’s disease and depression faster and more accurately.

“The challenge of trying to understand brain disorders has always been that they have been hard to measure objectively. It often comes down to asking patients how they feel, which has all sorts of problems,” says Brian Murphy, founder and chief scientific officer of BrainWaveBank.

Belfast-based BrainWaveBank has just raised €1.1m to help get the device through medical certification. Funding came from Par Equity and supported by current investors Techstart Ventures, Clarendon Fund Managers and Angel CoFund.

Read the full story on the Sifted website here

What are the investment size criteria for the Angel CoFund in terms of value and percentage of equity?
Read FAQs

Investment Team

Meet the team

We’re pretty sparing with our email comms, but when there are interesting and relevant things happening it’s great to share. If you’d like to receive updates and hear more about what is happening with ACF Investors and the portfolio then please sign up here.

Website by James Dowen Web Designer Web Developer Web design london